Revolution Medicines is a global, commercial-stage oncology company dedicated to discovering, developing, and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency, and hold ourselves to a high standard of rigor—all in service of patients. The Associate Director, US Compliance, Field Commercialization, reporting to the Sr. Director, Compliance, will serve as a primary compliance business partner in support of the company’s planned US commercialization activities for non-small cell lung cancer (NSCLC). The Associate Director is responsible for executing and managing the compliance strategy and program for NSCLC field organizations across Commercial and Medical. This role serves as a trusted compliance business partner to a range of business functions, providing actionable compliance guidance that enables compliant execution while advancing organizational objectives. The Associate Director will lead the development, implementation, and continuous enhancement of a comprehensive field compliance program, embedding compliance into field operations and supporting the company's growth. This role will proactively identify compliance risks, develop scalable solutions, and influence business decisions across a dynamic and evolving commercialization environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level